EPS Bio Technology Corp. (TPEX:4183)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
16.00
0.00 (0.00%)
Feb 10, 2026, 12:18 PM CST

EPS Bio Technology Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
497.19451.08470.17463.45480.28477.6
Revenue Growth (YoY)
2.51%-4.06%1.45%-3.50%0.56%3.97%
Cost of Revenue
421.63354.82354.46356.04359.61342.85
Gross Profit
75.5696.27115.71107.42120.67134.75
Selling, General & Admin
58.5159.3257.4157.9254.1358.92
Research & Development
33.4933.4333.2230.8832.2830.39
Operating Expenses
93.2790.8790.7991.487.6190.59
Operating Income
-17.715.424.9216.0133.0644.16
Interest Expense
-1.93-2.05-2.14-2.13-2.18-2.29
Interest & Investment Income
1.252.752.580.220.090.54
Currency Exchange Gain (Loss)
-1.4711.350.9713.15-7.55-2.52
Other Non Operating Income (Expenses)
0.380.360.390.210.110.19
EBT Excluding Unusual Items
-19.4817.8126.7227.4623.5240.07
Gain (Loss) on Sale of Assets
---0.26---
Pretax Income
-19.4817.8126.4627.4623.5240.07
Income Tax Expense
-5.240.55.472.14.888.37
Net Income
-14.2417.3120.9925.3618.6431.7
Net Income to Common
-14.2417.3120.9925.3618.6431.7
Net Income Growth
--17.54%-17.24%36.06%-41.20%71.93%
Shares Outstanding (Basic)
242424242424
Shares Outstanding (Diluted)
242424242424
Shares Change (YoY)
-0.05%-0.08%-0.10%0.03%-0.13%0.18%
EPS (Basic)
-0.600.730.881.070.781.33
EPS (Diluted)
-0.600.730.881.060.781.33
EPS Growth
--17.36%-16.98%35.90%-41.35%72.73%
Free Cash Flow
-18.23-46.2445.69-9.9620.3473.42
Free Cash Flow Per Share
-0.77-1.941.91-0.420.853.07
Dividend Per Share
0.6700.6700.8000.9800.7001.200
Dividend Growth
-16.25%-16.25%-18.37%40.00%-41.67%71.43%
Gross Margin
15.20%21.34%24.61%23.18%25.12%28.21%
Operating Margin
-3.56%1.20%5.30%3.45%6.88%9.25%
Profit Margin
-2.86%3.84%4.46%5.47%3.88%6.64%
Free Cash Flow Margin
-3.67%-10.25%9.72%-2.15%4.23%15.37%
EBITDA
-7.1815.6635.928.7247.0157.41
EBITDA Margin
-1.44%3.47%7.64%6.20%9.79%12.02%
D&A For EBITDA
10.5310.2610.9812.7113.9613.25
EBIT
-17.715.424.9216.0133.0644.16
EBIT Margin
-3.56%1.20%5.30%3.45%6.88%9.25%
Effective Tax Rate
-2.80%20.67%7.64%20.76%20.89%
Advertising Expenses
-3.03----
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.